This finding is consistent with previous studies in Western populations, where EGFR, KRAS, and ALK genetic alterations were reported to be predominantly mutually exclusive in NSCLC (Gainor et al., 2013). This evidence concerns the gene KRAS and non-small cell lung carcinoma.